|
Calabrò, Marco; Marco, Calabrò; Drago, Antonio et al. (2015) Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls. Psychiatry Res 228:945-9
|
|
Steinberg, S; de Jong, S; Mattheisen, M et al. (2014) Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry 19:108-14
|
|
Ramsey, Timothy L; Brennan, Mark D (2014) Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial. Schizophr Res 160:73-9
|
|
Ramsey, Timothy L; Liu, Qian; Massey, Bill W et al. (2013) Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study. Schizophr Res 149:21-5
|
|
Stroup, T Scott; Byerly, Matthew J; Nasrallah, Henry A et al. (2013) Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. Schizophr Res 146:190-5
|
|
Zhao, Zhongming; Webb, Bradley T; Jia, Peilin et al. (2013) Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis. PLoS One 8:e67776
|
|
Agim, Zeynep Sena; Esendal, Melda; Briollais, Laurent et al. (2013) Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PLoS One 8:e53042
|
|
Jackson, Kia J; Fanous, Ayman H; Chen, Jingchun et al. (2013) Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder. Psychiatr Genet 23:20-8
|
|
Greenbaum, L; Alkelai, A; Zozulinsky, P et al. (2012) Support for association of HSPG2 with tardive dyskinesia in Caucasian populations. Pharmacogenomics J 12:513-20
|
|
Keefe, Richard S E; Vinogradov, Sophia; Medalia, Alice et al. (2012) Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. J Clin Psychiatry 73:1016-22
|
Showing the most recent 10 out of 24 publications
